Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Recent Pharmacogenomics Papers of Note: Jul 24, 2013

Premium

Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients.
Li X, Qi W, Yao R, Tang D, Liang J.
Clin Transl Oncol. 2013 Jul 20. [Epub ahead of print]


Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
Miller FA, Hayeems RZ, Bytautas JP, et al.
Eur J Hum Genet. 2013 Jul 17. [Epub ahead of print]


Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service.
Nutescu EA, Drozda K, Bress AP, et al.
Pharmacotherapy. 2013 Jul 17. [Epub ahead of print]


Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.
Wang Z, Hong Z, Gao F, Feng W.
Mol Cell Biochem. 2013 Jul 18. [Epub ahead of print]


Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial.
Jiang ZF, Cristofanilli M, Shao ZM, et al.
Ann Oncol. 2013 Jul 14. [Epub ahead of print]


Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.
Alexander BM, Wen PY, Trippa L, et al.
Neuro Oncol. 2013 Aug;15(8):972-8. Epub 2013 Jul 14.


Genomic Alterations in Advanced Esophageal Cancer May Lead to Subtype-Specific Therapies.
Forde PM, Kelly RJ.
Oncologist. 2013 Jul 12. [Epub ahead of print]


Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implications.
Strimpakos AS, Syrigos KN, Saif MW.
JOP. 2013 Jul 10;14(4):359-62.


A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.
Kerr SE, Schnabel CA, Sullivan PS, et al.
Mod Pathol. 2013 Jul 12. [Epub ahead of print]


Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine.
Warneke VS, Behrens HM, Haag J, et al.
Diagn Mol Pathol. 2013 Jul 9. [Epub ahead of print]


Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor Dabrafenib (GSK2118436).
Nathanson KL, Martin AM, Wubbenhorst B, et al.
Clin Cancer Res. 2013 Jul 5. [Epub ahead of print]


Validation of a Proposed Warfarin Dosing Algorithm Based on the Genetic Make-Up of Egyptian Patients.
Ekladious SM, Issac MS, Sharaf SA, Abou-Youssef HS.
Mol Diagn Ther. 2013 Jul 10. [Epub ahead of print]


Validation study of a non-invasive urine test for diagnosis and prognosis assessment of bladder cancer. Evidence for improved models.
Mengual L, Ribal MJ, Lozano JJ, et al.
J Urol. 2013 Jul 2. [Epub ahead of print]


Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.